KURA ONCOLOGY, INC. (KURA) Operating cash flow 2016–2025
KURA ONCOLOGY, INC. (KURA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$64.1MFY2025 · since FY2016: -$25.3M → -$64.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.1M | -147.7% |
| FY2024 | $134.3M | +207.6% |
| FY2023 | -$124.8M | -13.4% |
| FY2022 | -$110.1M | -5.3% |
| FY2021 | -$104.6M | -49.7% |
| FY2020 | -$69.8M | -27.5% |
| FY2019 | -$54.8M | -12.5% |
| FY2018 | -$48.7M | -71.1% |
| FY2017 | -$28.4M | -12.2% |
| FY2016 | -$25.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice